Advertisement
Singapore markets open in 5 hours
  • Straits Times Index

    3,303.19
    +10.26 (+0.31%)
     
  • S&P 500

    5,180.76
    +52.97 (+1.03%)
     
  • Dow

    38,851.94
    +176.26 (+0.46%)
     
  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     
  • Bitcoin USD

    63,207.78
    -678.06 (-1.06%)
     
  • CMC Crypto 200

    1,358.73
    +46.10 (+3.52%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Gold

    2,332.80
    +24.20 (+1.05%)
     
  • Crude Oil

    78.57
    +0.46 (+0.59%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     
  • Hang Seng

    18,578.30
    +102.38 (+0.55%)
     
  • FTSE Bursa Malaysia

    1,597.39
    +7.80 (+0.49%)
     
  • Jakarta Composite Index

    7,135.89
    -7,134.72 (-50.00%)
     
  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

Pacira: 3Q Earnings Snapshot

Pacira: 3Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $640,000 in its third quarter.

The Parsippany, New Jersey-based company said it had a loss of 2 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 31 cents per share.

The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.

The specialty drugmaker posted revenue of $83.4 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $79.3 million.

ADVERTISEMENT

Pacira shares have increased nearly 8 percent since the beginning of the year. The stock has risen 53 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PCRX at https://www.zacks.com/ap/PCRX